entity

Ph

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Ph: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections

30Hypotheses

30Analyses

1Outgoing

0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

→

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Outgoing (2)

Target	Relation	Type	Str
HNRNPA2B1	modulates	protein	0.85

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Neutrophil Extracellular Trap (NET) Inhibition	0.700	-	Blood-brain barrier tight junction disru
Autophagy-Senescence Axis Therapeutic Window	0.700	-	Senescent cell clearance as neurodegener
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind	0.674	neuroimmunology	What is the temporal sequence of TREM2 s
Transcriptional Autophagy-Lysosome Coupling	0.665	neurodegeneration	Autophagy-lysosome pathway convergence a
Selective Acid Sphingomyelinase Modulation Therapy	0.648	neurodegeneration	Lipid raft composition changes in synapt

SASP-Driven Microglial Metabolic Reprogramming in Synaptic P	0.638	neurodegeneration	Senolytic therapy for age-related neurod
TREM2-Dependent Microglial Phagocytosis Acts as a Strain Sel	0.636	neurodegeneration	What are the specific molecular determin
Closed-loop tACS targeting entorhinal cortex layer II SST in	0.625	Alzheimer's disease	Circuit-level neural dynamics in neurode
Circadian Glymphatic Entrainment via Targeted Orexin Recepto	0.623	neurodegeneration	Perivascular spaces and glymphatic clear
Alpha-gamma cross-frequency coupling enhancement to restore	0.621	Alzheimer's disease	Circuit-level neural dynamics in neurode
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph	0.615	neurodegeneration	What is the therapeutic window between i
APOE-Dependent Autophagy Restoration	0.615	neurodegeneration	Mechanistic role of APOE in neurodegener
IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral	0.601	neuroinflammation	How do B cells mechanistically orchestra
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.599	neurodegeneration	What are the mechanisms by which gut mic
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43	0.598	neurodegeneration	What is the therapeutic window between i
SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduct	0.596	neurodegeneration	How do sphingomyelin/ceramide ratios spe
H7: Enteric Nervous System Alpha-Synuclein Propagation Block	0.595	neurodegeneration	How does engineered C. butyricum cross t
Selective Neutral Sphingomyelinase-2 Inhibition Therapy	0.591	neurodegeneration	Lipid raft composition changes in synapt
M1 Muscarinic Receptor Agonism as Pharmacological Exercise S	0.589	neurodegeneration	What are the specific circulating factor
TREM2 Agonism to Reprogram Infiltrated Monocytes Toward Neur	0.584	neurodegeneration	What are the specific molecular mechanis
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl	0.575	neuroscience	Circuit-level neural dynamics in neurode
ER Stress Reduction as Adjunctive Therapy to Support Autopha	0.566	neurodegeneration	Why does iron chelation therapy worsen o
Smartphone-Detected Motor Variability Correction	0.563	neurodegeneration	Digital biomarkers and AI-driven early d
Targeted Butyrate Supplementation for Microglial Phenotype M	0.559	neurodegeneration	What are the mechanisms by which gut mic
MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN	0.552	neuropharmacology	What determines blood-brain barrier pene
Circadian Clock-Autophagy Synchronization	0.547	neurodegeneration	Sleep disruption as cause and consequenc
Glymphatic-Mediated Tau Clearance Dysfunction	0.546	neuroscience	Circuit-level neural dynamics in neurode
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio	0.546	neurodegeneration	Lipid raft composition changes in synapt
Circadian Glymphatic Rescue Therapy (Melatonin-focused)	0.546	neurodegeneration	Sleep disruption as cause and consequenc
SGMS1-Driven Sphingomyelin Accumulation Impairs BACE1 Lysoso	0.542	neurodegeneration	What molecular mechanisms link elevated

Mentioning Analyses (30)

Scientific analyses that reference this entity

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.780

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650

What are the physiological functions of BACE1 beyond APP processing that could c

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.527

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

neurodevelopment | 2026-04-15 | 1 hypotheses Top: 0.576

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.542

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake [PMID:40439868]	Zheng Z, Xue F, Wang H, Gu Q, Hu R, Li X	Pharmacol Rep	2025	1
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798]	Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang	Cell Mol Gastroenterol Hepatol	2024	1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704]	Zhang T, Xu D, Trefts E, Lv M, Inuzuka H	Science	2023	1
Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466]	Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji	J Ethnopharmacol	2022	1
Genetic determinants of daytime napping and effects on cardiometabolic health. [PMID:33568662]	Dashti HS, Daghlas I, Lane JM, Huang Y,	Nat Commun	2021	1
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. [PMID:34052813]	Sun Y, Tisdale RK, Kilduff TS	Front Neurol Neurosci	2021	1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892]	Wang Y, An H, Liu T, Qin C, Sesaki H, Gu	Cell Rep	2019	1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310]	Song X, Zhu S, Chen P, Hou W, Wen Q, Liu	Curr Biol	2018	1
Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664]	Cid-Díaz T, Santos-Zas I, González-Sánch	J Cachexia Sarcopenia Muscle	2017	1
Sleep drives metabolite clearance from the adult brain. [PMID:24136970]	Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th	Science	2013	1
PTEN loss drives B7H3 upregulation via the mTORC2/FOXO/c-Myc axis to promote tum [PMID:41920736]	Wang Z, Jin N, Li X, Ma X, Feng Y, Yin K	Cell reports	2026	0
Mammalian lipophagy: process and function. [PMID:41681129]	Zhao R, Dai E, Kang R, Liu J, Klionsky D	Autophagy	2026	0
TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiqu [PMID:41921828]	["Xin Y", "Sun Y", "Pan E", "Li M", "Che	Free radical biology & medicin	2026	0
Combining network pharmacology and multi-omics reveals the role of Shengdihuang- [PMID:41655545]	Cao X, Shang Y, Qu M, Kang Q, Xu Y et al	Phytomedicine	2026	0
A PI3Kδ-Foxo1-FasL signaling amplification loop rewires CD4+ T cell signaling an [PMID:41718717]	Golec DP, Gazzinelli-Guimaraes PH, Chaus	J Exp Med	2026	0
Comparative transcriptomics of adherent and suspension chicken fibroblast cell l [PMID:41763754]	Contreras EJ, Nagarajan A, Bromberg BH,	Food Res Int	2026	0
FOXO1 transcription factor modulates airway epithelial responses to viral infect [PMID:41931532]	Daniel NM, Mann-Nüttel R, Shrestha Palik	PLoS One	2026	0
Clinical and immunological significance of FOXO1 as a biomarker of improved resp [PMID:41935603]	Du L, Wang J, Wang Y, Wang H, Xu X et al	Eur J Pharmacol	2026	0
Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cell [PMID:41945556]	Yan Z, Chi W, Yan Z, Wang H	PLoS One	2026	0
Ponatinib inhibits LCK and PI3K signaling and promotes CD8(+) T stem cell memory [PMID:41946709]	Okuhiro Y, Ito S, Watanabe K, Yan Y, Kum	Nat Commun	2026	0

Ph

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

nhp-validation-animal-model

coq10-neurodegeneration

NTF4 Protein

CLCN10 — Chloride Voltage-Gated Channel 10

Energy Metabolism Dysfunction Comparison Across Neurodegenerative Diseases

Vesicle Trafficking Dysfunction in Corticobasal Syndrome

APOC4 — Apolipoprotein C-IV

TREM2 Microglial Signaling Pathway in Neurodegeneration

Blood-Brain Barrier Biology and Crossing Strategies

deferiprone-neurodegeneration

GBA Pathway in Parkinson's Disease

Niemann-Pick Disease Type C (NPC)

LRRK2 Kinase Activation and Endolysosomal Dysfunction in Parkinson's Disease

Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's Disease

A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

LRRK2 Pathway in Parkinson's Disease

Outgoing (2)

Incoming (0)

Targeting Hypotheses (30)

Mentioning Analyses (30)

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

What are the physiological functions of BACE1 beyond APP processing that could c

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

Why does PRKN-mediated mitophagy, typically protective, cause harmful mitochondr

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

How does pericyte senescence mechanistically promote glioma cell growth and inva

What genetic risk factors predispose individuals to developing CTE following rep

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

What signals trigger microglia to specifically recognize and phagocytose LC axon

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

How does PSEN2 mechanistically regulate α-synuclein expression and pathology in

How do the seven novel ALS genes function in animal models to cause neurodegener

What molecular mechanisms enable microglia to neutralize OxPC-mediated neurodege

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis c

Which tau PTMs are both disease-specific and druggable with selective small mole

What are the specific molecular mechanisms by which peripheral monocytes cross t

Why have numerous phase 3 clinical trials failed despite advances in understandi

Extracellular vesicle biomarkers for early AD detection

Does human glymphatic function show clinically relevant circadian variation like

What determines the temporal transition from protective to pathological stress g

What are the molecular signatures that distinguish protective vs. harmful microg

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

Do chronic stress granule inhibition strategies impair normal cellular stress re

What are the optimal timing windows for TREM2 inhibition vs activation in Alzhei

Related Papers (20)